About J-GLOBAL

日本語

Font size
  • A
  • A

Articleの詳細情報

ArticleJ-GLOBAL ID:200902212411182141整理番号:04A0066519

新規MC4受容体きっ抗薬MCL0129(1‐[(S)‐2‐(4‐Fluorophenyl)‐2‐(4‐isopropylpiperadin‐1‐yl)ethyl]‐4‐[4‐(2‐methoxynapthalen‐1‐yl)butyl]piperazine)の抗不安作用

著者:島崎聡立(大正製薬 医薬研)、広田志帆(大正製薬 医薬研)、奥山茂(大正製薬 医薬研)・・・
資料名:日本神経精神薬理学雑誌 巻:23 号:6 ページ:336
発行年:2003年12月25日
  • J-GLOBAL home
  • Bookmark J-GLOBAL

J-GLOBAL: Linking, Expanding and Sparking

About J-GLOBAL

Linking

J-GLOBAL links information that represents the key to research and development. For example, linking articles and patents with people (authors and inventors) enables the extraction of a sequence of information.
It’s useful for making new discoveries and uncovering new information.

Expanding

The system enables searches of similar kinds of content through linkage with external sites.
It helps you to obtain knowledge from dissimilar fields and discover concepts that cross the boundaries of specialisms.

Sparking

Through repeated linkage and expansioniteration, J-GLOBAL provides unexpected hints for problem-solving and the illumination of new ideas.